|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-4-3
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To evaluate the safety and efficacy of abatacept plus methotrexate (MTX) over 5 years in patients with rheumatoid arthritis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
736-42
|
|
pubmed:meshHeading |
pubmed-meshheading:19273451-Antirheumatic Agents,
pubmed-meshheading:19273451-Arthritis, Rheumatoid,
pubmed-meshheading:19273451-Double-Blind Method,
pubmed-meshheading:19273451-Drug Therapy, Combination,
pubmed-meshheading:19273451-Humans,
pubmed-meshheading:19273451-Immunoconjugates,
pubmed-meshheading:19273451-Methotrexate,
pubmed-meshheading:19273451-Placebos,
pubmed-meshheading:19273451-Quality of Life,
pubmed-meshheading:19273451-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study.
|
|
pubmed:affiliation |
Department of Rheumatology, KU Leuven, Herestraat 49, B 3000 Leuven, Belgium. rene.westhovens@uz.kuleuven.ac.be
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
